Biotech’s Turning Up…
Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News.
We keep telling investors...
Dyadic (DYAI) Highlights.
"In just over a year and a half we have entered into over 15 proof of concept collaborations for both human and...
Mustang Bio (MBIO) Highlights.
"With a strong balance sheet and the continued advancement of our gene therapy and CAR T programs, we are well-positioned to execute...
Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...
We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff...
What We’re Watching.
“Biotech, Beverages and Bears - Oh My!”
— Daniel K. McMahon
Medtech Incubator in Final Stages of Launch.
TrueNature (TNTY) Has Spent the Past Year Gearing Up. News of a Launch and First Incubation Effort Could be Around the Corner...
Investor Presentation Slides From Dyadic (DYA) $6.40.
Really, How Do We Do It?
Live Short Term Chart
Healthcare Incubators and Wearable Devices.
Originally published August 22, 2019
The Global Wearable Devices Market is expected to exceed more than $51.50 billion by...
HCN Navigator Driving ‘Profit at First Touch’ for Hotels.
With more than 80 percent of guests using HCN interactive tablets daily, hoteliers are increasing revenues from onsite services sales and digital...
Innovus (INNV) Gains 75% in Past Week.
After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU).
Click...
Latest article
Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!
When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...
GeoVax to Provide Corporate Update on Tuesday May 14, 2024.
Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...
NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...
Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...
